NCT01406431.

Methods	Randomised, open‐label, cross‐over assignment
Participants	Healthy male volunteers Age 20‐55 years at the time of screening BMI 19‐26 kg/m2 at the time of screening
Interventions	Pitavastatin 4 mg (2 tablets), valsartan 160 mg (1 tablet). Other name: Livalo, Diovan Comparator drug: pitavastatin, valsartan
Outcomes	Primary Outcomes: ‐Cmax of study drugs after single oral administration ‐AUClast of study drugs after single oral administration Secondary Outcomes ‐AUCinf, Tmax and t1/2β of study drugs after single oral administration
Notes